Skip to content

Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool

Characterization and Comparison of the Human Microbiome in Peritoneum, Jejunum, Rectum and Stool

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04067440
Acronym
METABIOM
Enrollment
30
Registered
2019-08-26
Start date
2019-10-01
Completion date
2024-07-30
Last updated
2025-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis, Diabetes Mellitus, Fatty Liver, Nonalcoholic, Leaky Gut Syndrome, Obesity

Keywords

Microbiome, Obesity, Chronic Liver Disease

Brief summary

Characterization of the human microbiome in the jejunum and comparison to the microbiome in the rectum and stool in order to see how the microbial communities change within the intestines.

Detailed description

Subjects to undergo surgery with opening of the jejunum will be sampled with sterile swabs from peritoneum and the inside of the jejunum. A swab will also be taken from the rectum. The peritoneum is regarded as a sterile place until today. We try to either verify this, we also could find a scientific base for theories like leaky gut or other forms of bacterial migration through the intestinal wall. Many of these patients undergo bariatric surgery. Many of them do have a dramatic change in glucose metabolism immediate after surgery. Therefore stool swabs will be taken before and 5 days after surgery.

Interventions

DIAGNOSTIC_TESTMicrobial Swab

Swabs will be taken from peritoneum and jejunum (intraoperatively), rectum, and stool

Sponsors

Universität des Saarlandes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* abdominal surgery containing opening of jejunum * singing of consent

Exclusion criteria

* inflammative condition (appendicitis, pancreatitis, Crohn, Colitis ulcerous, cholecystitis and similar)

Design outcomes

Primary

MeasureTime frameDescription
Characterization of microbiomeintra-operativePreviously uncharacterized sites: jejunum, peritoneum

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026